NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Supervised Prehabilitation Program for Patients With Pancreatic Cancer

NCT05692323

Active Not RecruitingNA

Sponsor: Cedars-Sinai Medical Center

Conditions: Pancreas Cancer

Interventions: PREHAB

Countries: United States

The purpose of this study is to assess the use of an exercise program in people with pancreatic cancer.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Pancreatic cancer diagnosis (any stage)
* Age ≥ 18 years
* Independent ambulation and activities of daily living (Discretion of referring/ treating oncologist)
* Godin-Shephard Leisure-Time Physical Activity Questionnaire score of ≤ 23
* Physically able to complete functional assessments including 6-minute walk test, hand grip strength, short performance physical battery and performance metrics
* Answers no to all questions on PAR-Q OR is cleared to participate by their treating oncologist
* Ability to read, write and understand English
* Written informed consent obtained from subject and ability for subjects to comply with the requirements of the study

Inclusion criteria for remote monitoring of physical activity (Fitbit) and online Pain portal only (failure to meet inclusion criterion below should not preclude subjects from participating in main study):

* Access to a smart device capable of Fitbit syncing and accessing the online Pain portal (www.painguide.com)

Exclusion Criteria:

* Has undergone or plans to undergo resection surgery prior to projected completion of PREHAB exercise intervention
* Current pregnancy

Exclusion criteria for remote monitoring component of the study with Fitbit only (failure to meet exclusion criterion below should not preclude the subject from participating in main study):

* Using a pacemaker, implantable cardiac defibrillator, neurostimulator, cochlear implants (removable hearing aids permitted), or other electronic medical equipment, unless the PI deems study participation safe.

Locations (1)

Los Angeles, California, United States